New Breast and Facial Augmentation Solutions for Layered Fat Transfer Procedures With ATGRAFT(TM) by American CryoStem
December 18 2012 - 9:00AM
American CryoStem Corporation (OTCQB:CRYO) a leading biotech
company in the Regenerative Medicine industry is proud to announce
its latest adipose tissue storage service platform designed for
natural autologous layered fat transfer procedures, named ATGRAFT™.
ATGRAFT™ will be offered directly to cosmetic and plastic
surgeons who participate in the increasingly popular fat transfer
procedure market. This tissue storage platform gives physicians the
ability to offer their patient's affordable and reliable solutions
for multiple-layered fat transfer procedures by storing their
adipose tissue.
Patients are continually seeking natural alternatives for breast
and buttocks augmentations, facial enactments and hand volumizing
procedures. With ATGRAFT™, a patient can undergo a standard
liposuction and store their excess body fat as a natural
biocompatible filler for a fuller, more natural look and feel for
immediate or future use in cosmetic enhancement procedures.
Autologous fat transfer procedures have been used for many years
with no commercially available solution for layered procedures that
do not involve multiple liposuctions. Utilizing cryopreserved fat
for multiple-layered fat transfers increases patient overall
satisfaction and does not require a liposuction with each
procedure. The ATGRAFT™ adipose tissue storage service comes
"ready-to-use" and eliminates the significant expense to physicians
in maintaining an FDA compliant on-site laboratory and storage
facility to support advanced layering techniques.
American CryoStem's Medical Advisory Board member, an early
pioneer of Liposuction and the originator of Fat Transfer, Dr. Mel
Bircoll commented, "Given the ability to store and retrieve adipose
tissue with confidence of sterility and purity, will greatly
enhance the achievement of optimal contour and size in a host of
cosmetic and reconstructive procedures."
"The ATGRAFT™ service is a welcome solution and easy opportunity
for any surgeon offering or planning to incorporate fat transfer
procedures into their patient services. The greatest benefit to the
patient is, ATGRAFT is a viable alternative to reconstruction or
enhancement procedure that normally incorporates artificial fillers
and prosthetics." said Anthony Dudzinski, COO. "Our clinical tissue
storage program supports multiple-layered procedures which produces
the ultimate outcome for the patient as opposed to a one-time
procedure which often results in overstuffing and sizeable tissue
regression."
American CryoStem's ATGRAFT™ tissue storage customers also have
additional opportunities to further process portions of their
clinically prepared adipose tissue samples for future uses in
Regenerative Medicine therapies or to create personalized skin care
products made from their own adult stem cells.
Physicians that would like to offer ATGRAFT™ tissue storage
services to their patients should call 732-747-1007 or email
info@americancryostem.com for an informational kit.
About American CryoStem: American CryoStem
Corporation (OTCQB:CRYO) is a leading biotech company focused on
marketing its clinical processing services and patented products
for adipose (fat) tissue and adipose derived adult stem cells. Our
clinical tissue processing, patented cell culture media products
and tissue storage platform supports cosmetic and regenerative
medicine applications being developed globally. The Company
provides high quality, clinically processed viable cells, while at
the same time developing cutting edge applications, therapies,
patented laboratory products and services for consumer and
commercial applications.
CONTACT: Investor Relations Contact:
American CryoStem Corporation
732-747-1007
info@americancryostem.com
www.americancryostem.com
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jul 2023 to Jul 2024